Scientists are developing improved forms of genome editing, increasing the number of inherited diseases that CRISPR technology may one day treat. But research veterans have a warning: be prepared for surprises.
Join STAT’s Sharon Begley for an upcoming digital event with industry experts about the challenges of moving a potential therapy from the lab to patients.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
